Literature DB >> 16603579

Nationwide survey on acute heart failure in cardiology ward services in Italy.

Luigi Tavazzi1, Aldo P Maggioni, Donata Lucci, Giuseppe Cacciatore, Gerardo Ansalone, Fabrizio Oliva, Maurizio Porcu.   

Abstract

AIMS: Chronic heart failure (HF) is recognized as an important public health problem but little attention has been focused on acute-stage HF. METHODS AND
RESULTS: Nationwide, prospective, observational study setting 206 cardiology centres with intensive cardiac care units. During 3 months, 2807 patients diagnosed as having de novo acute HF (44%) or worsening chronic HF (56%) were enrolled. Acute pulmonary oedema was the presenting clinical feature in 49.6% of patients, cardiogenic shock in 7.7%, and worsened NYHA functional class in 42.7% of cases. Anaemia (Hb<12 g/dL) was present in 46% of patients, renal dysfunction (creatinine > or =1.5 mg%) in 47%, and hyponatraemia (< or =136 mEq/L) in 45%. An ejection fraction (EF)>40% was found in 34% of cases. Intravenous diuretics, nitrates, and inotropes were given to 95, 51, and 25% of patients, respectively. The median duration of hospital stay was 9 days. In-hospital mortality rate was 7.3%. Older age, use of inotropic drugs, elevated troponin, hyponatraemia, anaemia, and elevated blood urea nitrogen were independent predictors of all-cause death; prior revascularization procedures and elevated blood pressure were indicators of a better outcome. The rehospitalization rate within 6 months was 38.1%, all-cause mortality from discharge to 6 months was 12.8%.
CONCLUSION: Acute HF is an ominous condition, needing more research activity and resources.

Entities:  

Mesh:

Year:  2006        PMID: 16603579     DOI: 10.1093/eurheartj/ehi845

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  40 in total

Review 1.  Current management and future directions for the treatment of patients hospitalized for heart failure with low blood pressure.

Authors:  Mihai Gheorghiade; Muthiah Vaduganathan; Andrew Ambrosy; Michael Böhm; Umberto Campia; John G F Cleland; Francesco Fedele; Gregg C Fonarow; Aldo P Maggioni; Alexandre Mebazaa; Mandeep Mehra; Marco Metra; Savina Nodari; Peter S Pang; Piotr Ponikowski; Hani N Sabbah; Michel Komajda; Javed Butler
Journal:  Heart Fail Rev       Date:  2013-03       Impact factor: 4.214

2.  Treatment Approaches to Congestion Relief in Acute Decompensated HF: Insights After DOSE-AHF and CARRESS-HF.

Authors:  Simon F Shakar; JoAnn Lindenfeld
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-08

3.  Morphine Use in the Treatment of Acute Cardiogenic Pulmonary Edema and Its Effects on Patient Outcome: A Systematic Review.

Authors:  Víctor Gil; Alberto Domínguez-Rodríguez; Josep Masip; W Frank Peacock; Òscar Miró
Journal:  Curr Heart Fail Rep       Date:  2019-08

Review 4.  Vasopressin receptor antagonists in patients with chronic heart failure.

Authors:  R De Vecchis; C Cantatrione; D Mazzei
Journal:  Herz       Date:  2016-09-15       Impact factor: 1.443

Review 5.  Clinical review: practical recommendations on the management of perioperative heart failure in cardiac surgery.

Authors:  Alexandre Mebazaa; Antonis A Pitsis; Alain Rudiger; Wolfgang Toller; Dan Longrois; Sven-Erik Ricksten; Ilona Bobek; Stefan De Hert; Georg Wieselthaler; Uwe Schirmer; Ludwig K von Segesser; Michael Sander; Don Poldermans; Marco Ranucci; Peter C J Karpati; Patrick Wouters; Manfred Seeberger; Edith R Schmid; Walter Weder; Ferenc Follath
Journal:  Crit Care       Date:  2010-04-28       Impact factor: 9.097

Review 6.  Epidemiology of acute heart failure syndromes.

Authors:  François Alla; Faiez Zannad; Gerasimos Filippatos
Journal:  Heart Fail Rev       Date:  2007-06       Impact factor: 4.214

7.  Anaemia is an independent predictor of death in patients hospitalized for acute heart failure.

Authors:  Stephan von Haehling; Joerg C Schefold; Lea Majc Hodoscek; Wolfram Doehner; Marwan Mannaa; Stefan D Anker; Mitja Lainscak
Journal:  Clin Res Cardiol       Date:  2010-02       Impact factor: 5.460

Review 8.  Agents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyond.

Authors:  John R Teerlink; Marco Metra; Valerio Zacà; Hani N Sabbah; Gadi Cotter; Mihai Gheorghiade; Livio Dei Cas
Journal:  Heart Fail Rev       Date:  2009-12       Impact factor: 4.214

9.  Newer treatments for decompensated heart failure: focus on levosimendan.

Authors:  Ferenc Follath
Journal:  Drug Des Devel Ther       Date:  2009-09-21       Impact factor: 4.162

10.  Conivaptan and its role in the treatment of hyponatremia.

Authors:  Jalal K Ghali; Jareer O Farah; Suleiman Daifallah; Hassan A Zabalawi; Hammam D Zmily
Journal:  Drug Des Devel Ther       Date:  2009-12-29       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.